Publikationen in Zusammenarbeit mit Forschern von University Hospital of Lausanne (6)

2024

  1. Obinutuzumab Pretreatment as a Novel Approach to Mitigate Formation of Anti-Drug Antibodies Against Cergutuzumab Amunaleukin in Patients with Solid Tumors

    Clinical Cancer Research, Vol. 30, Núm. 8, pp. 1630-1641

2023

  1. Longitudinal analysis of DC subsets in patients with ovarian cancer: Implications for immunotherapy

    Frontiers in Immunology, Vol. 14

2021

  1. Beyond the lessons learned from the COVID-19 pandemic: opportunities to optimize clinical trial implementation in oncology

    ESMO Open

2020

  1. Quantitative and qualitative impairments in dendritic cell subsets of patients with ovarian or prostate cancer

    European Journal of Cancer, Vol. 135, pp. 173-182

2017

  1. Editorial: Cancer immunotherapy full speed ahead

    Annals of Oncology

2014

  1. T-cell and NK-cell infiltration into solid tumors: A key limiting factor for efficacious cancer immunotherapy

    Cancer Discovery, Vol. 4, Núm. 5, pp. 522-526